Symantec Endpoint Protection up to 14.3 RU5 on Windows authorization
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.4 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Symantec Endpoint Protection up to 14.3 RU5 on Windows. It has been declared as problematic. This affects an unknown function. Such manipulation leads to authorization. This vulnerability is referenced as CVE-2022-37017. No exploit is available. It is recommended to upgrade the affected component.
Details
A vulnerability was found in Symantec Endpoint Protection up to 14.3 RU5 on Windows (Anti-Malware Software). It has been rated as problematic. Affected by this issue is some unknown processing. The manipulation with an unknown input leads to a authorization vulnerability. Using CWE to declare the problem leads to CWE-863. The product performs an authorization check when an actor attempts to access a resource or perform an action, but it does not correctly perform the check. This allows attackers to bypass intended access restrictions. Impacted is confidentiality, integrity, and availability. CVE summarizes:
Symantec Endpoint Protection (Windows) agent, prior to 14.3 RU6/14.3 RU5 Patch 1, may be susceptible to a Security Control Bypass vulnerability, which is a type of issue that can potentially allow a threat actor to circumvent existing security controls. This CVE applies narrowly to the Client User Interface Password protection and Policy Import/Export Password protection, if it has been enabled.
The weakness was published 12/01/2022. The advisory is shared for download at support.broadcom.com. This vulnerability is handled as CVE-2022-37017 since 07/28/2022. There are neither technical details nor an exploit publicly available.
Upgrading to version 14.3 RU5 Patch 1 or 14.3 RU6 eliminates this vulnerability.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2022-39674). VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.symantec.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.5VulDB Meta Temp Score: 6.4
VulDB Base Score: 5.5
VulDB Temp Score: 5.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 7.5
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: AuthorizationCWE: CWE-863 / CWE-285 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Upgrade: Endpoint Protection 14.3 RU5 Patch 1/14.3 RU6
Timeline
07/28/2022 🔍12/01/2022 🔍
12/01/2022 🔍
06/18/2026 🔍
Sources
Vendor: symantec.comAdvisory: support.broadcom.com
Status: Confirmed
CVE: CVE-2022-37017 (🔍)
GCVE (CVE): GCVE-0-2022-37017
GCVE (VulDB): GCVE-100-214640
EUVD: 🔍
Entry
Created: 12/01/2022 17:45Updated: 06/18/2026 05:55
Changes: 12/01/2022 17:45 (39), 12/29/2022 08:41 (9), 12/29/2022 08:44 (3), 04/25/2025 02:49 (16), 06/18/2026 05:55 (1)
Complete: 🔍
Committer: ravedod881
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.